Are clinical trials the "gold standard" for cancer prevention research?

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3289-3291

  Kristal, Alan R ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; PLANT MEDICINAL PRODUCT; SELENOMETHIONINE; TRACE ELEMENT;

ANALYTICAL ERROR; BREAST CANCER; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CLINICAL TRIAL; DRUG RESEARCH; EDITORIAL; FAT INTAKE; FOOD COMPOSITION; HIGH RISK PATIENT; HUMAN; LOW FAT DIET; MAXIMUM TOLERATED DOSE; METHODOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RESEARCH DESIGN; SELENIUM; TIME FACTORS; VITAMIN E;

EID: 57449106848     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1066     Document Type: Editorial

References (14)

1. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97:94-102.
2. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
3. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-4.
4. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial [see comment]. JAMA 2006;295:629-42.
5. Centers for Disease Control. Trends in intake of energy and macronutrients - United States, 1971-2000. Morbidity Mortality Weekly Report 2004;53:80-2.
6. Hunter DJ, Spiegelman D, Adami H-O, et al. Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med 1996;334:356-61.
7. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1149-55.
8. Lanza E, Wanke K, Lee G, Sansbury L, Albert PS, Schatzkin A. Does the level of adherence to a low-fat, high-fiber, high-fruit and -vegetable eating pattern affect adenoma recurrence? Proc Am Assoc Cancer Res 2006;2006:B174.
9. Freedman LS, Potischman NA, Kipnis V, et al. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol 2006;35:1011-21.
10. Lucia MS, Epstein JI, Goodman PJ, et al. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007;99:1375-83.
11. Thompson IM, Chi C, Ankerst DP, et al. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst 2006;98:1128-33.
12. Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman CA, Thompson IM. Finasteride does not increase the risk of highgrade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res 2008;1:174-81.
13. Writing Group for the Women's Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
14. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-4.